PSA updates guidelines for salbutamol, terbutaline inhalers

Image: Supplied/TWC.
Pharmacists key to supporting asthma patient to move away from relievers and toward preventers, PSA leader says  Updated treatment guidelines for pharmacists supplying salbutamol and terbutaline inhalers to patients with asthma from the Pharmaceutical Society of Australia (PSA) aim to curb the overreliance on short-acting beta2-agonists (SABA).   Launching the revised guidelines, Dr Fei Sim,

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Second round of pharmacist prescriber training consultations underway
Next Mental health pharmacist integration: never a better time